Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Disitamab Vedotin with Lenvatinib and PD-1 inhibitors for HER2-positive advanced biliary tract cancer…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer [Phase 2]
Phase 2 study evaluating paclitaxel micelle in combination with immunotherapy for biliary tract cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial update evaluating trilaciclib for bone marrow protection during chemotherapy in advanced biliary tract cancer and p…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer [NA]
A clinical trial is currently recruiting to evaluate MiniPDX-based postoperative adjuvant therapy for biliary tract cancer.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Observational Monocentric Study on Biliary Tract Cancer (BABEL)
A monocentric observational study called BABEL focusing on biliary tract cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer [Phase 2]
A Phase 2, single-arm, multicenter exploratory trial is evaluating Adebrelimab plus Apatinib and systemic chemotherapy for initially unresec…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial evaluating a quadruple combination therapy (Trastuzumab Rezetecan, Pertuzumab, Iparomlimab, and Tuvonralimab) for b…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients. [Phase 2]
A Phase 2 clinical trial evaluating SPH5030 tablets for HER2-positive/mutated biliary tract cancer or colorectal cancer is currently recruit…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers [NA]
Mayo Clinic is recruiting for a study of Acceptance and Commitment Therapy for reducing cancer-related distress in patients with malignant h…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen [Phase 2]
A Phase II clinical study protocol evaluating a second-line liposomal irinotecan combination regimen for advanced biliary tract cancers; cur…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
The ACABi PRONOBIL study is investigating prognostic and predictive biomarkers of treatment response in patients with biliary tract cancer a…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. [Phase 2]
Phase 2 clinical trial evaluating durvalumab with tremelimumab, with or without paclitaxel, for advanced biliary tract cancer after platinum…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line [Phase 2]
Phase 2 clinical trial evaluating mFOLFOX/mFOLFIRI versus mFOLFOX as second-line therapy in advanced or recurrent biliary tract cancer; curr…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC [Phase 2]
This clinical trial update describes a Phase 2 study evaluating Recaticimab and Adebrelimab in combination with chemotherapy for unresectabl…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients [Phase 3]
A Phase 3 clinical trial is investigating trastuzumab added to first-line chemotherapy versus chemotherapy alone for HER2-positive advanced …
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors [Phase 2]
Phase 2 trial evaluating QL1706 in combination with lenvatinib and GEMOX as first-line therapy for unresectable biliary tract tumors.
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial evaluating BL-B01D1 in combination with a PD-1/PD-L1 monoclonal antibody for advanced biliary tract cancer is curre…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer [Phase 2]
Phase 2 study evaluating nab-paclitaxel, gemcitabine, and cisplatin in unresectable biliary tract cancer; the trial is active but not recrui…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) [Phase 2]
Phase 2 clinical trial update evaluating durvalumab and tremelimumab in combination with propranolol and chemotherapy for advanced hepatopan…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This trial update describes a dose-escalation and dose-expansion study of MDX2001 in patients with advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial is investigating sequential anti-angiogenic therapy after immunotherapy in advanced biliary tract cancers, includin…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer [Phase 2, Phase 3]
Phase 2/3 trial update assessing comprehensive geriatric management to reduce morbidity and improve quality of life in elderly patients unde…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1）
A clinical trial (BTC-IM-1) is evaluating the combination of GemCis (gemcitabine + cisplatin) with a PD-1/PD-L1 inhibitor in advanced biliar…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies [Phase 2]
Phase 2 clinical trial of Ivonescimab in combination with liposomal irinotecan and 5-FU/leucovorin for potentially resectable biliary tract …
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer
This update notes that the expanded access treatment protocol for Zanidatamab (ZW25) in patients with HER2-positive advanced biliary tract c…